Seminar
Immune-mediated control of Toxoplasma gondii in human cells
Toxoplasma gondii infects 30 percent of the world’s population, yet no countermeasures for humans exist. Infection leads to the rapid production of interferon gamma (IFNg), a proinflammatory cytokine that upregulates host defence mechanisms.
The Frickel lab studies the actions of IFN-gamma-mediated ubiquitin- and guanylate binding protein (GBP)-driven mechanisms that target Toxoplasma in various human cells. To aid our discoveries, we have developed an automated artificial-intelligence driven image analysis pipeline that can robustly classify host-Toxoplasma interplay.
Admission
Admission
Free and open to all with no ticket required. Entry is on a first come, first served basis.
Contact
Contact